[Humoral immunity to herpes simplex virus type 2 in cervical cancer].
The analysis of the results of serological studies revealed differences between the number of positively reacting sera from patients with cervical carcinoma and from normal women. The activity of complement-fixing and virus-neutralizing antibodies in the patients' sera and the frequency of their detection were higher than in the sera from normal subjects. These results in combination with other methods of laboratory examinations may be used for early detection of cervical carcinoma as well as for determination of high risk groups with regard to oncological diseases.
D000328:Adult; D000917:Antibody Formation; D003168:Complement Fixation Tests; D005260:Female; D006558:Herpes Genitalis / Q000276:immunology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009500:Neutralization Tests; D012008:Recurrence; D018139:Simplexvirus / Q000276:immunology*; D002578:Uterine Cervical Dysplasia / Q000276:immunology; D002583:Uterine Cervical Neoplasms / Q000276:immunology*
Gumoral'nyĭ immunitet k virusu prostogo gerpesa tipa 2 u bol'nykh rakom sheĭki matki.